SCHEMBL4112255

SCHEMBL4112255

CN(C)CCN(CCNC(=O)Nc1ccc(Br)cc1)C(=O)Nc1ccc(Br)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ ATM Q13315 1/20 0.49
▸ FPR2 P25090 3/20 0.47
▸ CNR1 P21554 1/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ FPR3 P25089 1/20 0.46
▸ HRH3 Q9Y5N1 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ NAMPT P43490 1/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ MCHR1 Q99705 1/20 0.42
▸ MAOA P21397 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24381846 0.87 POLB (0.65) POLBHTTATMFPR2CNR1
SCHEMBL4108277 0.85 EPHX1 (0.52) POLBMEN1KMT2ATDP1ALDH1A1
SCHEMBL4128393 0.84 MEN1 (0.52) POLBHTTATMFPR2CNR1
SCHEMBL4112186 0.84 MEN1 (0.60) POLBHTTCNR1MEN1KMT2A
SCHEMBL4115221 0.83 FPR3 (0.48) FPR2MEN1KMT2ATDP1FPR3
SCHEMBL7513232 0.82 FPR2 (0.57) POLBHTTATMFPR2CNR1
SCHEMBL4107298 0.80 MEN1 (0.55) POLBHTTATMCNR1MEN1
SCHEMBL4116418 0.80 MEN1 (0.52) POLBHTTATMFPR2CNR1
SCHEMBL4117727 0.79 CNR1 (0.60) POLBHTTCNR1MEN1KMT2A
SCHEMBL4119984 0.79 MEN1 (0.51) POLBFPR2CNR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118330-A1 Diurea derivatives ACTIVE BIOTECH AB (SE) 2009-05-07 — — US claimed
EP-1711175-A1 DIUREA DERIVATIVES Active Biotech AB (SE) 2006-10-18 — — EP claimed
WO-2005074919-A1 DIUREA DERIVATIVES ACTIVE BIOTECH AB (SE) 2005-08-18 — — WO claimed
US-20090118330-A1 Diurea derivatives ACTIVE BIOTECH AB (SE) 2009-05-07 — — US disclosed
EP-1711175-A1 DIUREA DERIVATIVES Active Biotech AB (SE) 2006-10-18 — — EP disclosed
WO-2005074919-A1 DIUREA DERIVATIVES ACTIVE BIOTECH AB (SE) 2005-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118330-A1 Diurea derivatives IL2, CASP2, MAVS POLB 2764/4885HTT 3669/4885ATM 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback